Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1
Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1
SAN DIEGO, CA / ACCESSWIRE / September 30, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" thanks to its user-friendly and affordable design, will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2024 Investor Conference, taking place virtually on October 1, 2024.
加利福尼亞州聖地亞哥/ACCESSWIRE/2024年9月30日/Modular Medical, Inc.（納斯達克股票代碼：MODD）（「模塊化醫療」 或 「公司」）是一家胰島素輸送技術公司，由於其用戶友好且價格合理的設計，其首款貼片泵專門針對所有成人 「幾乎是抽血者」 設計，將參加網絡直播演講，並在Lytham Partners2024年秋季投資者會議上與投資者進行一對一的會議，虛擬上於 2024 年 10 月 1 日舉行。
Company Webcast
公司網絡直播
The Company's webcasted presentation will take place at 2:00 p.m. Eastern Time on Tuesday, October 1. The webcast can be accessed by visiting the conference home page at and will also be available for replay following the event.
該公司的網絡直播演示將於美國東部時間10月1日星期二下午 2:00 舉行。可以通過訪問會議主頁訪問網絡直播，也將在活動結束後重播。
1×1 Meetings
1×1 會議
Jeb Besser, the Company's Chief Executive Officer, will host virtual one-on-one meetings throughout the event. To arrange a meeting with Mr. Besser, please contact Lytham Partners at 1×1@lythampartners.com or register for the event at .
公司首席執行官傑布·貝瑟將在整個活動期間主持虛擬的一對一會議。要安排與貝瑟先生的會面，請致電 1× 1@lythampartners.com 與 Lytham Partners 聯繫或通過以下地址註冊參加該活動。
About Modular Medical
關於模塊化醫療
Modular Medical, Inc. (Nasdaq: MODD) is a medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the Company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Modular Medical's mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."
Modular Medical, Inc.（納斯達克股票代碼：MODD）是一家醫療器械公司，打算推出下一代胰島素輸送技術。該公司利用其專利技術，力求消除複雜性和功效之間的權衡，從而使高質量的胰島素注射既經濟實惠又易於學習。Modular Medical的使命是改善糖尿病患者獲得最高標準血糖控制的機會，使其不僅限於 「超級用戶」，並提供 「爲我們其他人提供糖尿病護理」。
Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at .
模塊化醫療由經驗豐富的醫療器械專業人員和微流控工程師保羅·迪佩爾納創立。在創立模塊化醫療之前，diPerna先生是Tandem Diabetes的創始人（2005年），他發明並設計了其t: slim胰島素泵。更多信息可在以下網址獲得。
All trademarks mentioned herein are the property of their respective owners.
此處提及的所有商標均爲其各自所有者的財產。
CONTACT:
聯繫人：
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com
Jeb Besser
首席執行官
模塊化醫療有限公司
+1 (617) 399-1741
IR@modular-medical.com
SOURCE: Modular Medical, Inc.
資料來源：模塊化醫療公司